Trane Technologies' Mixed Q3 Results, Booking Deceleration Weigh on Sentiment, Oppenheimer Says
MT newswire2026/10/30 16:33Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
12:33 PM EDT, 10/30/2026 (MT Newswires) -- Trane Technologies' (TT) shares declined following mixed Q3 results and sequential deceleration in bookings that weighed on sentiment, Oppenheimer said in a note Friday. The brokerage said, however, it continues to view the company's strong pipeline, expanding data center thermal management portfolio and improving transport recovery trends as supportive of bookings growth in the coming quarters. The company reported Q3 adjusted EPS of $4.86 and revenue of $6.76 billion, both above consensus estimates of $4.73 and $6.5 billion, respectively, while adjusted EBITDA of $1.45 billion was below consensus of $1.46 billion. Management noted that the deceleration in Q3 order growth was due to lumpiness in data center orders, despite a record pipeline. The $8 billion in post-2026 backlog offers visibility into sustained 2027 growth, according to the note. The brokerage raised its 2026 estimates and now forecasts revenue and adjusted EPS of $24.23 billion and $15.27, compared with prior estimates of $23.98 billion and $15.24, respectively. Oppenheimer kept an outperform rating on Trane Technologies and lowered its price target to $500 from $530. Shares of Trane Technologies were down 3.9% in Friday trading. Price: 414.25, Change: -16.86, Percent Change: -3.91
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Wedbush lowers the target price for Cerebras Systems to $190.
格隆汇•2026/11/09 12:36
BUZZ-Zura Bio shares plummet after mid-stage trial failure of skin disease drug
路透社•2026/11/09 12:31

Netcapital Gets Nasdaq Extension Until Feb. 9 to File Overdue Reports
Bitget•2026/11/09 12:30

Crypto prices
MoreBitcoin
BTC
$74,804.4
-1.37%
Ethereum
ETH
$2,125.27
-4.93%
Tether USDt
USDT
$0.9987
+0.01%
BNB
BNB
$685.8
-1.69%
USDC
USDC
$0.9998
+0.01%
XRP
XRP
$1.1
-4.91%
Solana
SOL
$86.65
-3.05%
TRON
TRX
$0.3174
-0.90%
Zcash
ZEC
$1,217.49
-3.89%
Hyperliquid
HYPE
$73.68
-4.66%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now